US Stock MarketDetailed Quotes

ACORQ Acorda Therapeutics

Watchlist
  • 0.250
  • -0.008-3.10%
15min DelayClose Jun 14 16:00 ET
310.52KMarket Cap-1P/E (TTM)

About Acorda Therapeutics Company

Acorda Therapeutics, Inc. is a biopharmaceutical company that focuses on developing therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), and Fampyra (fampridine). The firm also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.

Company Profile

SymbolACORQ
Company NameAcorda Therapeutics
Listing DateFeb 10, 2006
Founded1995
CEODr. Ron Cohen, M.D.
MarketPink Market
Employees102
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2 Blue Hill Plaza,3rd floor,Pearl River
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10965
Phone1-914-347-4300
Websitehttp://www.acorda.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ron Cohen, M.D.
  • Director, President and Chief Executive Officer
  • 984.15K
  • Kerry Clem
  • Chief Commercial Officer
  • 592.23K
  • Michael A. Gesser
  • Treasurer, Chief Financial Officer and Principal Accounting Officer
  • 459.15K
  • John P. Kelley
  • Non-Executive Chairman of the Board
  • 127.49K
  • Dr. Peder K. Jensen, M.D.
  • Independent Director
  • 76.03K
  • Thomas Burns
  • Independent Director
  • --
  • John Varian
  • Independent Director
  • 114.83K
  • Dr. Sandra Panem,PhD
  • Independent Director
  • 72.64K
  • Neil S. Belloff
  • General Counsel and Corporate Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg